Hamilton Health Sciences Corporation

7 trials 6 recruiting Academic / non-commercial

Filter these 7 trials by condition, phase, country and more.

Open in Search →

7 Registered trials

6 Recruiting

0 Completed trials

14 Countries active

13 Unique IMPs

N/A Results reported

Phase III

Phase IV

Phase III: 5 Phase IV: 2

Oversight events:

1 temporary halt 5 corrective measures across 2 trials

View oversight register →

Top indications

Atrial fibrillation 2 Aortic valve replacement 1 Haemorrhage intracranial 1

Top IMPs

COLCHICINE 2 EDOXABAN 1 THIAMINE HYDROCHLORIDE 1

All trials

7 total

EdoxabaN foR IntraCranial Hemorrhage survivors with Atrial Fibrillation Pending

2024-518508-31-00 Phase IV 10 countries EDOXABAN
Low dose ColchicinE in pAtients with peripheral artery DiseasE to address residual vascular Risk: A randomized trial- LEADER PAD Recruiting

2024-512091-35-01 Phase III 4 countries COLCHICINE
Prospective Randomized Evaluation of Emerging Novel Treatments for Infection prophylaxis in Total Joint Replacement (PREVENT-iT) Recruiting

2024-515055-38-00 Phase III 1 country
COLchicine and Thiamine in Heart Failure due to Ischemic Heart Disease (COLT-HF) Recruiting

2023-506675-96-00 Phase III 1 country COLCHICINE; THIAMINE HYDROCHLORIDE
The Direct Oral Anticoagulation versus Vitamin K Antagonist after Cardiac Surgery (DANCE) Trial Recruiting

2023-504504-28-00 Phase III 1 country
Anticoagulation for Stroke Prevention In patients with Recent Episodes of Atrial Fibrillation occurring transiently with stress Recruiting

2023-509142-35-00 Phase IV 10 countries
Low INR to Minimize bleeding with mechanical valves Trial (LIMIT) Recruiting

2023-508532-56-00 Phase III 6 countries

Showing 1–7 of 7 trials

← All sponsors A–Z